(Total Views: 133)
Posted On: 12/01/2020 11:01:17 AM
Post# of 104871
$SBFM Up .0128 (+11.30%) Sunshine Biopharma Receives Third Tranche From Previously Announced $2,000,000 + Financing For Coronavirus Treatment
MONTREAL, QC / ACCESSWIRE / December 1, 2020 / Sunshine Biopharma Inc. (OTCPINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received the third tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $800,000 that the Company has received under this financing. The proceeds will be used for the ongoing development of the Company's Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company's flagship anticancer compound targeted for pancreatic cancer.
https://www.barchart.com/story/stocks/quotes/...-treatment
MONTREAL, QC / ACCESSWIRE / December 1, 2020 / Sunshine Biopharma Inc. (OTCPINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received the third tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $800,000 that the Company has received under this financing. The proceeds will be used for the ongoing development of the Company's Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company's flagship anticancer compound targeted for pancreatic cancer.
https://www.barchart.com/story/stocks/quotes/...-treatment
(0)
(0)Scroll down for more posts ▼
